Women with pending Depo-Provera brain tumor lawsuits have until November 30, 2026 to register for Pfizer’s settlement program, according to an order from the federal judge overseeing the cases. Women who don’t register, or who don’t qualify, will keep litigating their cases in court.
The lawsuits claim the Depo-Provera birth control shot raised the risk of meningioma, a tumor that grows on the membranes around the brain and spinal cord and is usually not cancerous, and that Pfizer failed to warn women and their doctors. As of November 2, 2026, 6,413 Depo-Provera cases were pending in the federal multidistrict litigation, MDL No. 3140, before U.S. District Judge M. Casey Rodgers in the Northern District of Florida, according to the Judicial Panel on Multidistrict Litigation.
How the settlement came together
On June 15, 2026, the plaintiffs’ lead lawyers announced a settlement covering a majority of the claims in the federal MDL and in New York state court. After the announcement, Judge Rodgers canceled the first trial, which had been set for December 7, 2026. The parties signed the master settlement agreement in July.
The total amount Pfizer agreed to pay has not been disclosed. In a July 27 order, Judge Rodgers described the deal as a private agreement governed by a confidentiality agreement. Because the MDL is not a class action, the settlement does not go through a court fairness review, but the judge noted that she had expressed the opinion that it “offers an excellent outcome to thousands of eligible litigants.” The court’s order says roughly 80% of the women with cases in the MDL are expected to be eligible.
What the November 30 deadline means
In an August 10 case management order, the court noted that the deadline for claimants to register for the settlement program is November 30, 2026. The settlement administrator, BrownGreer, decides who is eligible and reports to the court on women who are not.
The deadline applies to women who already have a case, or who hired a lawyer by June 11, 2026 and are entering the program through a special court docket the judge set up in September. It is not a deadline to file a new lawsuit outside the program. Women with a pending case can ask their lawyer to confirm that their registration is complete before November 30.
Who is left out
The court’s order describes two main groups of women who cannot join the program. “Limitations Plaintiffs” are ineligible because of the date they filed their lawsuit. “Latency Plaintiffs” are ineligible because of the timing of their meningioma diagnosis compared with their last Depo-Provera shot. The order does not publish the exact cutoffs.
The court plans separate proceedings for those two groups. Women who qualify but decide not to take part, women found ineligible for other reasons, and women who file new cases will keep litigating. The order gives them 90 days to meet medical record and expert report requirements, and cases that miss those requirements can be dismissed. Judge Rodgers has said the court will still rule on Pfizer’s preemption defense and on general causation, the question of whether Depo-Provera can cause meningioma, for these cases. Those rulings will not affect women who take part in the settlement.
When payments may start
The parties told the court that registration should be completed in November 2026, with payments beginning to roll out by the first quarter of 2027. On October 29, the court entered an order setting up the qualified settlement fund that will hold the money. The next case management conference is set for December 18, 2026. The court posts its Depo-Provera orders online.
LegalScoops first covered these claims when the Depo-Provera brain tumor lawsuits began to surge in late 2024. For how a mass tort settlement like this one differs from a class action settlement, see Mass Tort vs Class Action Explained in Plain English.
Common Questions
Is the Depo-Provera settlement a class action?
No. The Depo-Provera cases are a mass tort, where each woman has her own lawsuit. Because it is not a class action, the settlement does not go through a court fairness review. Each eligible woman decides whether to take part.
How much is Pfizer paying?
The total has not been made public. The court has described the deal as a private agreement covered by a confidentiality agreement, and individual amounts are set through the settlement program.
Is November 30 the deadline to file a Depo-Provera lawsuit?
No. November 30, 2026 is the deadline to register for the settlement program, mainly for women with pending cases. Under the court’s August order, cases filed in the future are handled as litigating cases outside the program, and filing deadlines for any new case depend on state law.
Where are the lawsuits pending?
Most of the lawsuits are in MDL No. 3140 before U.S. District Judge M. Casey Rodgers in the Northern District of Florida. Others are pending in state courts, including New York, whose cases are part of the settlement, as well as Minnesota, Delaware and California.



